Market Place
Sourcing Support
Ventyx Bio to Participate in 3 Upcoming Investor Conferences
12 Nov 2024 //
GLOBENEWSWIRE
Ventyx Biosciences Reports Q3 2024 Financial Results & Progress
07 Nov 2024 //
GLOBENEWSWIRE
Ventyx Biosciences Presents 52-Week Results From Phase 2 Trial
15 Oct 2024 //
GLOBENEWSWIRE
Sanofi makes $27M equity investment in Ventyx
23 Sep 2024 //
FIERCE BIOTECH
Ventyx Starts Phase 2a Trial Of VTX3232 In Early Parkinson`s Disease
06 Sep 2024 //
GLOBENEWSWIRE
Ventyx Biosciences Announces Departure of Chief Financial Officer
30 Aug 2024 //
GLOBENEWSWIRE
Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
28 Aug 2024 //
GLOBENEWSWIRE
Ventyx Biosciences Reports Q2 2024 Results And Highlights Progress
08 Aug 2024 //
GLOBENEWSWIRE
Ventyx Reports Phase 2 Results Of VTX958 In Crohn`s Disease
29 Jul 2024 //
GLOBENEWSWIRE
Ventyx`s last hope for inflammatory med ends in phase 2 Crohn`s failure
29 Jul 2024 //
FIERCE BIOTECH
Ventyx Bio: CNS NLRP3 Inhibitor Shows Metabolic/Inflammatory Benefits
05 Jun 2024 //
GLOBENEWSWIRE
Ventyx Appoints Matthew Moore As Chief Operating Officer
16 May 2024 //
GLOBENEWSWIRE
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
16 May 2024 //
GLOBENEWSWIRE
Ventyx Biosciences Q1 2024 Financials And Corporate Progress
09 May 2024 //
GLOBENEWSWIRE
Ventyx Biosciences to Report First Quarter 2024 Financial Results on May 9, 2024
02 May 2024 //
GLOBENEWSWIRE
Ventyx Biosciences Reports Clinical Data for its NLRP3 Inhibitor Portfolio
11 Mar 2024 //
GLOBENEWSWIRE
Ventyx Biosciences Announces $100 Million Private Placement of Common Stock
07 Mar 2024 //
GLOBENEWSWIRE
Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
06 Mar 2024 //
GLOBENEWSWIRE
Ventyx Biosciences to Host Virtual Investor Event on March 11, 2024
04 Mar 2024 //
GLOBENEWSWIRE
Ventyx Biosciences earnings beat by $0.08
28 Feb 2024 //
PRESS RELEASE
Ventyx Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results
27 Feb 2024 //
GLOBENEWSWIRE
Ventyx Biosciences to Present Results of the Phase 2 Trial of VTX002
22 Feb 2024 //
GLOBENEWSWIRE
Ventyx Biosciences to Participate in the Oppenheimer 34th Annual Conference
06 Feb 2024 //
GLOBENEWSWIRE
Ventyx to Participate in the 35th Annual Piper Sandler Healthcare Conference
21 Nov 2023 //
GLOBENEWSWIRE
Ventyx Biosciences to Participate in the Jefferies London Healthcare Conference
10 Nov 2023 //
GLOBENEWSWIRE
Ventyx Biosciences Reports Third Quarter 2023 Financial Results
09 Nov 2023 //
GLOBENEWSWIRE
Ventyx stock drops 70% as TYK2 inhibitor psoriasis plans halted
07 Nov 2023 //
FIERCE BIOTECH
Ventyx Biosciences Announces Results from the Phase 2 Trial of VTX958
06 Nov 2023 //
GLOBENEWSWIRE
Ventyx misses with investors amid comparisons to BMS, Pfizer
10 Oct 2023 //
FIERCE BIOTECH
Ventyx Biosciences Announces Positive Results from the Phase 2 Trial of VTX002
09 Oct 2023 //
GLOBENEWSWIRE
Ventyx Insider Sold Shares Worth $449,699, According to a Recent SEC Filing
05 Oct 2023 //
PRESS RELEASE
Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
30 Aug 2023 //
GLOBENEWSWIRE
Ventyx Biosciences Reports Second Quarter 2023 Financial Results
10 Aug 2023 //
GLOBENEWSWIRE
Ventyx Bio to Report Second Quarter 2023 Financial Results on August 10, 2023
03 Aug 2023 //
GLOBENEWSWIRE
Ventyx to Participate in the Canaccord Genuity 43rd Annual Growth Conference
02 Aug 2023 //
GLOBENEWSWIRE
Why did Ventyx Biosciences stock drop today? Large shareholder sale
07 Jul 2023 //
SEEKING ALPHA
Why Shares of Ventyx Biosciences Rose Monday
03 Jul 2023 //
FOOL
Ventyx Biosciences Announces Initiation of Dosing in a Phase 1 Trial of VTX3232
14 Jun 2023 //
GLOBENEWSWIRE
Ventyx Bio Announces Completion of Enrollment of the Phase 2 Trial of VTX002
07 Jun 2023 //
GLOBENEWSWIRE
Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
31 May 2023 //
GLOBENEWSWIRE
Ventyx Biosciences Reports First Quarter 2023 Financial Results
11 May 2023 //
GLOBENEWSWIRE
Ventyx Biosciences to Report 1Q FYR 2023 on May 11, 2023
04 May 2023 //
GLOBENEWSWIRE
Ventyx Biosciences, Inc. (NASDAQ:VTYX) Q4 2022 Earnings Call Transcript
27 Mar 2023 //
FINANCE YAHOO
Ventyx to Participate in the H.C. Wainwright Autoimmune Conference
24 Mar 2023 //
GLOBENEWSWIRE
Ventyx Biosciences 4Q & 2022 FYR and Highlights Recent Corporate Progress
23 Mar 2023 //
GLOBENEWSWIRE
Ventyx to Report Fourth Quarter and Full Year 2022 Financial Results
15 Mar 2023 //
GLOBENEWSWIRE
Ventyx Biosciences Provides Update on Silicon Valley Bank Financial Exposure
11 Mar 2023 //
GLOBENEWSWIRE
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
28 Feb 2023 //
GLOBENEWSWIRE
Ventyx Announces Highlights Strategic Priorities at Investor R&D Day
26 Jan 2023 //
GLOBENEWSWIRE
Ventyx Appoints Allison J. Hulme and Onaiza Cadoret-Manier to Board of Directors
12 Jan 2023 //
GLOBENEWSWIRE
Ventyx Biosciences to Host R&D Event on January 26, 2023
05 Jan 2023 //
GLOBENEWSWIRE
Ventyx Announces Dosing of First Patient in the Ph2 SERENITY Trial of VTX958
01 Dec 2022 //
GLOBENEWSWIRE
Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
22 Nov 2022 //
GLOBENEWSWIRE
Ventyx Biosciences Reports 3Q FYR and Highlights Recent Corporate Progress
03 Nov 2022 //
GLOBENEWSWIRE
Ventyx Biosciences to Participate in Three Upcoming Investor Conferences
27 Oct 2022 //
GLOBENEWSWIRE
Ventyx seeks to rack up $176M+ in its move as the market become bullish on TYK2
19 Sep 2022 //
ENDPTS
Ventyx Biosciences Announces $176.6 Million Private Placement of Common Stock
19 Sep 2022 //
GLOBENEWSWIRE
Why Ventyx Biosciences Zoomed Nearly 60% Higher This Week
16 Sep 2022 //
FOOL
Ventyx Biosciences (VTYX) Stock: Why It Surged 64.98%
13 Sep 2022 //
PRESS RELEASE
Ventyx Biosciences to Participate in Two Upcoming Investor Conferences
29 Aug 2022 //
GLOBENEWSWIRE
